Maplight Therapeutics, Inc. · NASDAQ:MPLT
Lillie James Woodruff sold 721 Maplight Therapeutics, Inc. shares (Form 4)
Traded May 7, 2026 · Filed May 11, 2026
On May 7, 2026, Lillie James Woodruff (Chief Scientific Officer) sold 721 Maplight Therapeutics, Inc. shares at US$28.28 for US$20,390 under a trading plan, leaving 242,729 shares. Filed May 11, 2026 (Form 4).
- Sold
- 721 shares
- Price
- US$28.28
- Value
- US$20,390
- Holding after
- 242,729 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Voting Common Stock | Sale | 721 | US$28.28 | 242,729 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Lillie James Woodruff
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Lillie James Woodruff · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Aug 19, 2026
- Form 4 · Lillie James Woodruff · Aug 4, 2026
- Form 4 · Lillie James Woodruff · Jul 17, 2026
- Form 4 · Lillie James Woodruff · May 6, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026